Exon duplication and divergence in the human preproglucagon gene
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“and while GIP-mediated weight loss is fully preserved in Glp1r-deficient mice45,49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIP-driven weight loss is also synergistically enhanced by adjunct GLP-1R agonism47-49,117.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Organization and Expression of Eucaryotic Split Genes Coding for Proteins
Breathnach, R., & Chambon, P. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002025 · Cited by 4,548
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,797
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., & Roe, B. A. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90196-5 · Cited by 3,407
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
The structure and evolution of the human β-globin gene family
Efstratiadis, A. (1980) · Cell · doi:10.1016/0092-8674(80)90429-8 · Cited by 1,375
Research works printed but not linked: 2
- Unger, R. H.& Orci, L. (eds) Glucagon, Physiology, Pathophysiology and Morphology of the Pancreatic A-cell (Elsevier, New York, 1981).
- O'Farrell, P. Focus 3 (3), 1–3 (1981).
Cited by
Items 401–500 of 595
Chapter 6. Formation and Degradation of Neuropeptides
Nispen, J. W. V., & Pinder, R. M. (1986) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61116-1 · Cited by 9
Role of somatostatin in regulation of insular-acinar axis
M�ller, M. K., Sch�nfeld, J. V., & Singer, M. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01308617 · Cited by 8
N-acetyl oxyntomodulin30?37: pharmacokinetics and activity on gastric acid secretion
Carles-Bonnet, C., Jarrousse, C., Niel, H., Martínez, J., Rolland, M., & BATAILLE, D. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00175470 · Cited by 8
Biosynthesis and Regulation of Expression. The Vasoactive Intestinal Peptide Gene
Gozes, I. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb26974.x · Cited by 11
Glucagon-like peptide-1 and the entero-insular axis in obese hyperglycaemic (ob/ob)mice
Bailey, C. J., & Flatt, P. R. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90364-x · Cited by 8
Cyclic-AMP-dependent phosphorylation of glicentin
Conlon, J. M., Thim, L., Moody, A. J., & Söling, H. (1984) · Bioscience Reports · doi:10.1007/bf01122224 · Cited by 8
Oxyntomodulin and related peptides control somatostatin secretion in RIN T3 cells
Tani, T., Quellec, A. L., Jarrousse, C., Sladeczek, F. A. J., Martínez, J., Estival, A., Pradayrol, L., & BATAILLE, D. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90107-9 · Cited by 8
GLUCAGON-LIKE PEPTIDE-1 IN THE RAT PANCREAS
Manaka, H., TANIGUCHI, H., WADA, K., Takahashi, H., Takahashi, K. A., Katagiri, T., & Sasaki, H. (1987) · Biomedical Research · doi:10.2220/biomedres.8.1 · Cited by 8
Post-translational proteolytic processing of precursors to regulatory peptides
Andrews, P., Brayton, K. A., & Dixon, J. E. (1989) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9136-3_11 · Cited by 8
He, S., Han, C., Wang, C., Huo, X., Feng, L., Wang, Y., Tian, X., & Cui, J. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134358 · Cited by 7
Haselmann, K. F., Nielsen, P. F., & Zubarev, R. A. (2005) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2005.01.009 · Cited by 7
The Effect of Dependence in a Binary Sequence on Tests for a Changepoint or a Changed Segment
Avery, P. J. (2001) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/1467-9876.00231 · Cited by 7
Short Chain Fatty Acids, Intestinal Adaptation, and Nutrient Utilization
McBurney, M. I., Reimer, R. A., & Tappenden, K. A. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5967-2_15 · Cited by 7
Bioactivity of a modified human Glucagon-like peptide-1
Xu, F., Wang, K. Y., Wang, N., Li, G., & Liu, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171601 · Cited by 7
Rovira, A., Garrote, F. J., Pascual, J. M., Salvador, M. G., Pombo, J. L. H., & Valverde, I. (1985) · Diabetologia · doi:10.1007/bf00279920 · Cited by 7
Role of peptide YY and enteroglucagon after low anterior resection
Hallböök, O. J., Adrian, T. E., Permert, J., & Staab, P. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02081418 · Cited by 7
The islet-acinar axis of the pancreas: Is there a role for glucagon or a glucagon-like peptide?
Schönfeld, J. V., & Müller, M. K. (1994) · Cellular and Molecular Life Sciences · doi:10.1007/bf01920743 · Cited by 7
Freychet, P., Brown, M. S., & Goldstein, J. L. (1990) · Springer eBooks · doi:10.1007/978-94-011-3060-8_11 · Cited by 7
Immunoreactive glucagons purified from dog pancreas, stomach and ileum
Shinomura, Y., Eng, J., & Yalow, R. S. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90230-3 · Cited by 8
Ontogeny of glucagon messenger RNA and encoded precursor in the rat intestine
Jin, S.-L. C., Hynes, M., & Lund, P. K. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90075-8 · Cited by 7
Ismail, A., Amer, M. S., & Tawheed, A. (2025) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v16.i3.107148 · Cited by 7
Shirani, A., & Stüve, O. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2587277 · Cited by 7
Shen, J., Wang, M., Pang, G., Zhang, Y., Zhang, J., Shi, Y., Liu, J., & Zhan, C. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00528.2024 · Cited by 7
Exercise Improves Spatial Learning and Memory Performance through the Central GLP-1 Receptors
Taati, M., Barzegar, P. E. F., & Raisi, A. (2022) · Behavioural Neurology · doi:10.1155/2022/2900628 · Cited by 6
Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1
Holst, J. J. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.9.1409 · Cited by 6
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_12 · Cited by 6
Molekulare Grundlagen der Adipositas
Hebebrand, J., Hinney, A., & Oeffner, F. (2001) · Springer eBooks · doi:10.1007/978-3-642-56858-9_12 · Cited by 14
Hara, M., Varndell, I. M., Bishop, A. E., Aitchison, M., Rode, J. W., Yamada, T., Green, D. M., Bloom, S. R., & Polak, J. M. (1987) · Molecular and Cellular Probes · doi:10.1016/0890-8508(87)90010-7 · Cited by 6
Creutzfeldt, W., & Ebert, R. (1988) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027311-9.50014-7 · Cited by 7
Use of glucagon-like polypeptide 2 analogs for intestinal failure
Goldschmidt, M. L., Oliveira, S. B., Slaughter, C., & Kocoshis, S. A. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2431291 · Cited by 5
Incretins and Development of Incretin‐based Therapeutics
Zheng, N., Su, X., Zhang, S., & Shen, W. (2025) · Wiley eBooks · doi:10.1002/9781119824701.ch09 · Cited by 6
Andrzejczak, K., Kucharczyk, E., Korgiel, M., Drozdowska, J., Maj, J., & Ponikowska, M. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050605 · Cited by 7
Gastrointestinal hormones: History, biology, and measurement
Rehfeld, J. F., & Goetze, J. P. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.11.004 · Cited by 6
Holst, J. J. (2024) · The Journal of Physiology · doi:10.1113/jp287461 · Cited by 5
Supramolecular oral delivery technologies for polypeptide-based drugs
Chen, J., Liu, T., Wang, M., Lü, B., Bai, D., Shang, J., Chen, Y., & Zhang, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.045 · Cited by 5
A Conservative Test for Multiple Comparison Based on Highly Correlated Test Statistics
Ninomiya, Y., & Fujisawa, H. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00821.x · Cited by 5
Description and application of a novel glucagon-like peptide-1 (GLP-1) radioimmunoassay
Lelesz, B., Tóth, G. K., Peitl, B., Hegedűs, C., Drimba, L., Sári, R., Szilvássy, Z., & Németh, J. (2013) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-013-2751-0 · Cited by 5
Decrease in plasma GLP-1 immunoreactivity in starved rats
Takahashi, J., Noma, Y., Yoshimoto, S., Fujita, C., & Shima, K. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90026-n · Cited by 6
GIP1–39, a novel insulinotropic peptide form and aspects on its mechanism of action
Xie, L., Lu, J., Östenson, C., Xu, T., & Chen, Z. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.04.013 · Cited by 5
Léger, C., Ni, A., Andonegui, G., Wong, J., Mowat, C., & Winston, B. W. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00310.2009 · Cited by 5
POST‐TRANSLATIONAL MODIFICATION OF PEPTIDE MESSENGERS IN THE GUT
Dimaline, R. (1988) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1988.sp003224 · Cited by 6
Holst, J. J. (1988) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027311-9.50016-0 · Cited by 5
Nauck, M. A., Schmidt, W. E., & Meier, J. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_12 · Cited by 5
Rushakoff, R. J., Liddle, R. A., Williams, J. A., & Goldfine, I. D. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74098-5_7 · Cited by 5
Intestinal Proglucagon-Derived Peptides
Brubaker, P. L., & Drucker, D. J. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-695-9_20 · Cited by 7
GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
Patel, T., Rose, J., Katsurada, K., Yada, T., Koutakis, P., Salomon, J., Patel, K. P., & Alfaidi, M. (2026) · Circulation Research · doi:10.1161/circresaha.126.327683 · Cited by 4
The role of PANDER and its interplay with IL-6 in the regulation of GLP-1 secretion
Li, Z., Pei, L., Xiao, H., Chen, N., Lai, F., Yue, S., Xu, C., Li, Y., Xiao, H., & Cao, X. (2024) · Endocrine Connections · doi:10.1530/ec-23-0548 · Cited by 5
Su, Y., Zhang, S., Wu, Z., Liu, W.-T., Chen, J., Deng, F., Chen, F., Zhu, D., & Hou, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1054946 · Cited by 5
GLP 1/2, Enteroglucagon, Glicentin, and Oxyntomodulin
Holst, J. J., Deacon, C. F., & Pedersen, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00168-8 · Cited by 5
Dinucleotide repeat polymorphism in the human glucagon gene (GCG)
Wu, S., Xiang, K., & Bell, G. I. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.5.1163 · Cited by 4
Self-citationTeranishi, H., Muneoka, Y., Takao, T., Shimonishi, Y., & Kojima, M. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.04.024 · Cited by 4
Treatment Strategies for Type 2 Diabetes Based on Incretin Action
Gallwitz, B., & Nauck, M. A. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-13 · Cited by 5
Glucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 5
Kushiyama, A., Kikuchi, T., Tanaka, K., Tahara, T., Takao, T., Onishi, Y., Yoshida, Y., Kawazu, S., & Iwamoto, Y. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i11.230 · Cited by 4
Gastrointestinal Peptide Hormones Regulating Energy and Glucose Homeostasis
Drucker, D. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50009-x · Cited by 5
The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective
Conlon, J. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.683089 · Cited by 4
Effect of ageing on pancreatic hyperplasia after 90% proximal small bowel resection
Sasaki, M., Sakamoto, K., Fujiyama, Y., & Bamba, T. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00446.x · Cited by 4
Regulatory peptide immunocytochemistry at light and electron microscopical levels
Noorden, S. V., & Varndell, I. M. (1989) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9136-3_2 · Cited by 4
Portha, B., Liu, J., Movassat, J., & Tourrel‐Cuzin, C. (2024) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2024.09.003 · Cited by 3
Zheng, M., Zhang, S., Wang, Y., Xie, N., Wang, X., Lv, J., Pang, X., & Xu, L. (2025) · Foods · doi:10.3390/foods14101785 · Cited by 3
Lee, J. J., Bajgain, P., & Lightner, A. L. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2026.1790420 · Cited by 3
Cantini, G., Trabucco, M., Dicembrini, I., Mannucci, E., & Luconi, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00016-x · Cited by 3
Liu, J., Wang, X., Zhang, W., Liao, G., Shao, Z., Brosius, J., Deng, C., Lai, S., & Long, E. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023133 · Cited by 3
Ding, H., Wang, M., Zhang, J., Wan, C., Huang, Z., Liu, L., & Liu, J. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00174.2025 · Cited by 5
El GLP-1: acción biológica y posibles efectos terapéuticos
Valverde, I., Cancelas, J., & Villanueva-Peñacarrillo, M. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71100-7 · Cited by 6
Zhang, Y., Wei, Y., Ma, B., Qiao, K., Ma, Z., Li, C., Ma, C., Ji, Y., Dong, Z., Hao, J., et al. (2013) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-013-9346-z · Cited by 3
Production of Bioactive Peptide in Transgenic Rice Seed
Wakasa, Y., Yang, L., & Takaiwa, F. (2009) · Agronomy monograph/Agronomy · doi:10.2134/agronmonogr51.c5 · Cited by 4
Gut-Derived Hormones—Cardiac Effects of Ghrelin and Glucagon-Like Peptide-1
Ruozi, G., Bortolotti, F., & Recchia, F. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00006-3 · Cited by 5
Silibinin protects GLUTag cells from PA-induced injury via suppressing endoplasmic reticulum stress
Shi, X., Chu, C., Li, X., Zhang, L., Zhang, X., Chen, N., Liu, W., Jiao, Z., Ikejima, T., & Xu, F. (2023) · CyTA - Journal of Food · doi:10.1080/19476337.2023.2222787 · Cited by 3
Historical overview of incretin based therapies
Bhansali, A., Maji, D., Rao, P. V. C., Banerjee, S., & Kumar, H. D. (2010) · Journal of the Association of Physicians of India · Cited by 7
Odegard, P. S., & DeSantis, A. J. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s4444 · Cited by 3
An overview of glucagon research
Valverde, I. (2016) · Diabetologia · doi:10.1007/s00125-016-3946-z · Cited by 3
Potential of GLP-1 in Diabetes Management
Holst, J. J., Nauck, M. A., Deacon, C. F., & Ørskov, C. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_18 · Cited by 3
Chapter 7 Molecular aspects of the glucagon gene
Laser, B., & Philippé, J. (1997) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(97)80038-5 · Cited by 9
Schwartz, T. W. (1984) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)97876-8 · Cited by 3
Ørskov, C., Hjorth, S. A., Jensen, A. D., & Vilsbøll, T. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.007 · Cited by 3
STRUCTURE OF PRECURSORS DERIVED FROM THE SEQUENCES OF CLONED cDNAs
Rutter, W. J., Scott, J., Selby, M., Crawford, R. J., Shen, L., Hobart, P. M., Sánchez-Pescador, R., & Bell, G. I. (1983) · Elsevier eBooks · doi:10.1016/b978-0-12-417320-0.50028-7 · Cited by 3
Self-citationWilliams, J. A. (2014) · doi:10.3998/panc.2014.7 · Cited by 4
Ismail, R. (2020) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10468 · Cited by 5
Editorial: Proglucagon-Derived Peptides
Flatt, P. R., Knop, F. K., & Tarasov, A. I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.776871 · Cited by 3
Helal, M. M., Almosilhy, N. A., Abo‐elnour, D. E., Jaffal, R., Allam, E. G., Almosilhy, M. A., Batarseh, S. F., & Meshref, M. M. (2026) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2026.2627901 · Cited by 3
Incretin-Based Therapies: A Novel Pathway in Addiction Treatment
Rosiejka, D., Joanna, M., Marcickiewicz, J., Bogdańska, A., Błażejewska, W., & Szulińska, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041613 · Cited by 2
Meiners, K., Stepic, T., Meinel, L., & Lühmann, T. C. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00041j · Cited by 3
The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms
Davies, I., Holst, J. J., ROSENKILDE, M. M., & Tan, T. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061824-043740 · Cited by 3
Glucagon receptor family in GtoPdb v.2023.1
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2023.1 · Cited by 2
Malíková, J. K., & Lebl, J. (2023) · Česko-slovenská pediatrie · doi:10.55095/cspediatrie2023/024 · Cited by 2
GIP und GLP-1-Rezeptoragonismus in der Therapie des Typ 2 Diabetes mit Fokus auf Tirzepatid
Nauck, M. A., Blüher, M., Meyhöfer, S. M., Heitmann, E., & Görgens, S. W. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2102-2436 · Cited by 3
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_12 · Cited by 3
Autotransplantation Modulates Ileal Enteroendocrine Cell Expression in the Pig
Lauronen, J., Pakarinen, M. P., Kuusanmäki, P., Halttunen, J., & Paavonen, T. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2000.6032 · Cited by 2
Is OM-3 synergistic with GLP-2 in intestinal failure?
Karmaker, A., Costanzo, C. M., & Schwartz, M. Z. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.08.018 · Cited by 2
Cytotoxicity of oxide anodized titanium alloy evaluated by cell and organic culture study.
Kanematu, N., Shibata, K. I., KURENUMA, S., Watanabe, K., Yamagami, A., Nishio, Y., & Fujii, T. (1990) · PubMed · Cited by 2
GÓRSKA, A., & Arciszewski, M. B. (2020) · Medycyna Weterynaryjna · doi:10.21521/mw.6374 · Cited by 3
Synthesis and Biochemical Characterization of Proglucagon- Related Peptides
Yanaihara, N., Mochizuki, T., Sato, T., Imai, S., Sasaki, K., Kakuyama, H., Hosoe, H., Takatsuka, N., Iguchi, K., Luo, W.-Q., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17470.x · Cited by 2
Development of new incretin drugs: Promising therapies
Kaur, K., & Gautam, C. (2006) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.24614 · Cited by 2
Cytochemical techniques for studying the diffuse neuroendocrine system
Bishop, A. E., & Polak, J. M. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)68059-7 · Cited by 2
Foundational contributions of Svetlana Mojsov to the GLP-1 field
Bárány, G., & Barany, M. J. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00069 · Cited by 2
Portha, B., Liu, J., Movassat, J., & Tourrel‐Cuzin, C. (2025) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2025.05.006 · Cited by 1
Cui, Y., Liu, B., Wu, T., Zhang, Z., & Yuan, H. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10182-6 · Cited by 1
Curto, R., Giglione, C., Cannarella, R., Berisha, H., Hattab, R., Condorelli, R. A., Vignera, S. L., Calogero, A. E., & Magni, P. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108278 · Cited by 2
Metadata
- Authors
- Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C.
- ORCID
- Laybourn, Paul J.
- Venue
- Nature
- Published
- 1983-07
- Volume
- 304
- Issue
- 5924
- Pages
- 368-371
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003141714
- Cited by
- 593
- References
- 36
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 10 · 2016: 16 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 13
- FWCI
- 36.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- exon duplication, glucagon, glucagon-like peptide-1, glucagon-like peptide-2, signal peptide, gene structure
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Glucagon, Cricetinae, Humans, Insulin, Proinsulin, Protein Precursors, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.